|
|
10 Panel Drug Test
This is a 10 Panel Multi-Drug Test Card.
It has 10 panels (ten parameters) to test for 10 types of drugs. This is
an all inclusive drugs of abuse Dip Test for drug screening of ten drugs at one
time. This dip strip tests for the following drugs: THC
(MARIJUANA) • COCAINE • PCP • OPIATES •
METHAMPHETAMINES • METHADONE • AMPHETAMINES
• BARBITURATES
• BENZODIAZEPINES
•
Tricyclic Antidepressants
|
Our 10 Panel Test is a rapid One-step
Diagnostic Drug of Abuse Test to Screen for Ten (10)
targeted Illicit and Prescription Drugs
and their Metabolites at the Minimum Cutoff Sensitivity Levels Established by
the National Institute on Drug Abuse, World Health
Organization (WHO) and SAMHSA. Approximately 95% of abused
drugs in use today are detectable using this one simple, easy to use, drug
testing device. An economical, all inclusive drug of abuse scan for rapid point
of contact results. Indicated for pre-employment screening and general testing
when drug use is suspected and the specific abused drug is unknown. |
INTENDED USE OF DRUG TEST KIT
This Multi-Drug 10 Panel Test is an forensic, all inclusive, point of use
screening test for the rapid detection of 11-nor- delta 9 -Tetrahydrocannabinol
-9- carboxylic acid (THC/Marijuana), Cocaine and its metabolite, benzoylecgonine,
PCP (Phencyclidine), Morphine and its related metabolites derived from opium
(opiates), Methamphetamines (including Ecstasy*),
Methadone, Amphetamines, Barbiturates,
Benzodiazepines and Tricyclic Antidepressants
(TCA)
in human urine at or above the system concentrations
levels established as standard minimums by the National Institute on Drug Abuse
(NIDA), the World Health Organization (WHO)
and SAMHSA as shown in the chart to the right. Note system cut-off
concentrations are expressed in nanograms per
milliliter solution.
*While Methamphetamine tests will
generally detect MDMA (Ecstasy), an
MDMA
specific test is recommended when screening specifically for MDMA or Ecstasy
use.
|
10 Panel Drug Test Dip |
 |
Description
#DIP-1001- Cocaine (COC),
Amphetamine (AMP), Methamphetamine (mAMP), Marijuana (THC),
Methadone (MTD), Opiates (OPI), Phencyclidine (PCP), Barbiturates
(BAR), Benzodiazepines (BZO) & Tricyclic Anti-depressants (TCA). |
|
|
SUMMARY AND EXPLANATION OF DRUG TESTING
Urine based screening tests for drugs of
abuse range from simple immunoassay tests to complex analytical procedures. The
speed and sensitivity of lateral flow based immunoassays identical to that
employed in our Multi-Drug 10 Panel Drug Test have made them the most widely
accepted method for screening urine for drugs of abuse. our Multi-Drug Screen
Panel Test is based on the principle of the highly specific immunochemical
reactions of antigens and antibodies which are used for the analysis of specific
compounds in human urine. This Multi-Drug Screen Test is a rapid, visual,
competitive panel immunoassay that can be used for the simultaneous, qualitative
detection of the ten (10) targeted drugs and their metabolites listed above. For
a description of these drugs of abuse along with other useful background
information please refer to the
Drug Test FAQ page. This Ten Panel
Multi-Drug Test
is intended as an initial forensic screen for the presence of drug or drug
metabolites at the time the test is performed. Because the test requires visual
interpretation, it is recommended that a person other than the test subject
interpret test results.
|
SYMBOL |
TARGET DRUG |
CONC. |
|
THC |
MARIJUANA |
50 ng/ml |
|
COC |
COCAINE |
300 ng/ml |
|
PCP |
PHENCYCLIDINE |
25 ng/ml |
|
OPI |
OPIATES |
2000
ng/ml |
|
MET |
METHAMPHETAMINE |
1000 ng/ml |
|
MTD |
METHADONE |
300 ng/ml |
|
AMP |
AMPHETAMINE |
1000 ng/ml |
|
BAR |
BARBITURATES |
300 ng/ml |
|
BZO |
BENZODIAZEPINES |
300 ng/ml |
|
TCA |
TRICYCLIC ANTIDEPRESSANT |
1000 ng/ml |
|
|
DRUG TEST PROCEDURE
1. Read the enclosed instruction
manual completely.
2. Do not open the sealed test pouch until just prior
to sample testing.
3. Collect a fresh urine sample in a clean container
preferably glass.
4. Check the expiration date and remove the test
device from the sealed pouch. Do not use the test past its expiration date.
Remove the test cap exposing the 10 absorbent wicks. Do not touch the wicks or
otherwise contaminate them.
5. Dip the wicks only into
the urine sample for approximately 20-30 seconds or until visible sample
migration up the wicks and across
the tests panels is observed.
6. Dip only the wicks. Do not allow
the sample to come in contact with any other part of the test device or its
plastic housing.
7. Read result within 3 to 8 minutes after the
addition of samples. Do not read result after 8 minutes. If the drug test is
left standing for longer than 8 minutes, the intensity of the colored lines may
change or for technical reasons, a faint line may appear that should not be
interpreted.
8. Photocopy both sides of the test
card for a permanent record of test results.
INTERPRETATION OF DRUG TEST RESULTS
Negative: Colored lines adjacent to each target drug name and in
the control (C) regions will appear. The color intensity of the line for the
target drug may be weaker or stronger than that of the control line however any
line, no matter how faint should be interpreted as a negative result. Do not
attempt to correlate the intensity or color of the test lines between the
targeted drug panels. Also because development times vary for each target drug,
results should not fully interpreted until 6-8 minutes
have elapsed. Some drug panels, however, will develop test lines within 3
minutes or less producing negative results.
A very faint line on the test region may indicate that the target drug in
the sample is near the cutoff level for the test. While these results should be
considered negative, confirmation of the sample by more analytical testing
methods may be desired.
Positive: Colored lines
appear in the control regions (C) but do not develop in the test region. The
absence of any line in any target drug test region indicates a positive result
for that drug or drug metabolite. The example shown is a positive test for THC
and Opiates
and negative test for all other drugs. Note that test lines are not of equal
intensity or color. Because of the various sensitivity cutoff level for each
specific drug this result is normal.
Invalid: No line appears
in the control region. Under no circumstances should a positive sample be
identified until the control line (C) forms in the control test area. If the
control line (C) does not form, the test result is inconclusive and the assay
should be repeated with a new test device.
Note: our Multi-Drug 10 panel test is used to obtain visual qualitative result
and is not intended as a quantitative assay.. This assay provides only a
preliminary analytical test result as to the presence of the target drug and
drug metabolites at the established minimum standards above. A more specific
alternative chemical method must be used in order to obtain a confirmed
analytical result. Gas chromatography! mass spectrometry (GC/MS) has been
established as the preferred confirmatory method by the Substance Abuse Mental
Health Services Administration (SAMHSA). Clinical consideration and professional
judgment should be applied to any drug of abuse test result, particularly when
preliminary positive results are indicated. If confirmation of positive drug
test is required, we suggest
Laboratory Confirmation of positive drug test results.
AVAILABILITY AND
ORDERING
Our Multi-Drug 10 Panel Drug Test Card tests for approximately 95% of the abused
illicit
and prescription drugs in one simple to use, easy to read, all inclusive
device. Test
cassettes are individually and hermetically sealed in a foil package
clearly stamped with lot number and expiration date. A comprehensive instruction
sheet is included covering greater detail on test procedure, clinical accuracy
and cross-reactivity charts. This Multi-Drug 10 Panel test is available in any
quantity. For bulk quantities and discount prices, call 801-596-2709.
See Also our
New 12 Panel Drug Test which
covers even more drugs!
|